Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance
Circulation: Population Health and Outcomes · 2026
DOI: 10.1161/circoutcomes.125.012828 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Population Health and Outcomes, 2026. Verfasst von Ian J Neeland und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH (I.J.N., S.R.). Hauptthemen laut MEDLINE: Cardio-Renal Syndrome, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Metabolic Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Cardiovascular diseases (CVD) are leading causes of morbidity and mortality among patients with cardiovascular-kidney-metabolic syndrome. Adoption of guideline-directed medical therapy remains suboptimal. Our objective was to evaluate the impact of a team-based multisite care model on improving quality and reducing disparities in patients with cardiovascular-kidney-metabolic syndrome. METHODS: We conducted a prospective clinical cohort study across 9 US sites of the Cardiometabolic Center Alliance, a network of health care organizations with a standardized approach to address CVD risk, between May 2020 and August 2024. Consecutive patients with type 2 diabetes/prediabetes and CVD and chronic kidney disease were enrolled in a clinical program with team care, structured visits, and standardized assessments. Cardiometabolic risk factor levels and proportion of adherence to guideline-directed medical therapy were assessed using longitudinal mixed-effects models accounting for clustering by site. RESULTS: Two thousand two hundred twenty-three individuals were enrolled with a mean (SD) age of 63.9 (11.2) years, 44.2% female, 84.0% White, and 62.5% noncommercially insured; 58.5% had atherosclerotic CVD, 32.6% heart failure, and 29.5% chronic kidney disease. Median follow-up was 6.8 (4.0–9.4) months. Participants had reductions in weight (mean [95% CI], −16.7 [−17.9 to −15.6] lbs), body mass index (−2.6 [−2.8 to −2.4] kg/m 2 ), systolic (−5.8 [−7.0 to −4.6] mm Hg) and diastolic (−1.7 [−2.4 to−0.9] mm Hg) blood pressure, total cholesterol (−26.4 [−29.5 to −23.2] mg/dL), low-density lipoprotein cholesterol (−18.8 [−21.4 to −16.2] mg/dL), triglycerides (−45.1 [−54.0 to −36.3] mg/dL), fasting glucose (−30.9 [−35.4 to −26.4] mg/dL), HbA1c (−1.2 [−1.3% to −1.0%]), and insulin dose (−30.4 [−36.1 to −24.8] units/d), P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH (I.J.N., S.R.).
- Division of Cardiovascular Medicine, University Hospitals Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, OH (I.J.N., A.K., S.R.).
- Saint Luke's Michael & Marlys Haverty Cardiometabolic Center of Excellence, Kansas City, MO (M.L.M., A.J.S., M.N.K.).
- Cardiometabolic Center Alliance, American Heart Association, Dallas, TX (M.L.M., D.S.A., A.S., A.J.S.).
- Major Health Partners, Shelbyville, IN (E.A.K.A., A.B., L.H.).
- Heart and Vascular Center, Essentia Health, Duluth, MN (C.P.B.).
ORCID-Profile: Ian J Neeland, Audrey Kwun, Daniel S Aistrope, Catherine P Benziger, Natalia De Albuquerque Rocha, Javed Butler, Robert H Eckel, Kensey Gosch, Allyson R Helms, Adedapo Iluyomade, Jorge Plutzky, Andrea Stafos, Andrew J Sauer, Sanjay Rajagopalan, Mikhail N Kosiborod
Förderung
- NHLBI NIH HHS
Zitieren
APA
Neeland, I. J., Magwire, M. L., Kwun, A., Aistrope, D. S., Andaya, E. A. K., Bashall, A., Benziger, C. P., De Albuquerque Rocha, N., Butler, J., Davis, L., Denicola, D., Eckel, R. H., Gosch, K., Harness, L., Helms, A. R., Iluyomade, A., Miller, K. A., Gianos, E., Donahoe, S., …, & Kosiborod, M. N. (2026). Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance. Circulation: Population Health and Outcomes. https://doi.org/10.1161/circoutcomes.125.012828
Vancouver
Neeland IJ, Magwire ML, Kwun A, Aistrope DS, Andaya EAK, Bashall A, et al. Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance. Circulation: Population Health and Outcomes. 2026. doi:10.1161/circoutcomes.125.012828
BibTeX
@article{Neeland2026,
author = {Neeland, Ian J and Magwire, Melissa L and Kwun, Audrey and Aistrope, Daniel S and Andaya, Emily Ann Kapunan and Bashall, Anthony and Benziger, Catherine P and De Albuquerque Rocha, Natalia and Butler, Javed and Davis, Lisa and Denicola, Dawn and Eckel, Robert H and Gosch, Kensey and Harness, Lacy and Helms, Allyson R and Iluyomade, Adedapo and Miller, Keith A and Gianos, Eugenia and Donahoe, Sean and Patel, Shachi and Plutzky, Jorge and Stafos, Andrea and Sauer, Andrew J and Rajagopalan, Sanjay and Kosiborod, Mikhail N},
title = {Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance},
journal = {Circulation: Population Health and Outcomes},
year = {2026},
doi = {10.1161/circoutcomes.125.012828}
}
EUVIMED